Transthyretin Cardiac Amyloidosis - novel and emerging treatments
Transthyretin cardiac amyloidosis was until recently considered an untreatable disease. However, this underdiagnosed pathology experienced a surge in research interest with multiple novel treatments, including several first-in-class drugs rapidly approaching the final stages of investigation, with t...
| Autor principal: | |
|---|---|
| Formato: | masterThesis |
| Idioma: | eng |
| Publicado em: |
2021
|
| Assuntos: | |
| Texto completo: | https://hdl.handle.net/10216/134566 |
| País: | Portugal |
| Oai: | oai:repositorio-aberto.up.pt:10216/134566 |